Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience
- PMID: 37533171
- DOI: 10.1111/vox.13499
Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience
Abstract
Background and objectives: Bone marrow (BM) harvesting is one of the essential sources of stem cells for haematopoietic stem cell transplantation. In 2019, commercial BM collection kits became unavailable in Europe. Consequently, we created an in-house BM collection kit as an alternative.
Materials and methods: We compared two groups of BM collections. The first collections were taken using an in-house kit from June 2022 through February 2023 and the second with a commercial kit from February 2021 through May 2022. These all took place at seven collection centres (CC). We analysed the harvest quality (cell blood count, CD34+ cells, viability, potency and sterility), the incidents occurring with each kit and the time to neutrophil and platelet engraftment in recipients.
Results: A total of 23 donors underwent BM harvesting with the in-house kit and 23 with the commercial one. Both cohorts were comparable regarding donor characteristics, CC and time to procedure. No statistical differences were found in harvest quality between the in-house and commercial kits. A new transfusion set was required in three BM harvests (13%) with the in-house kit because of filter clogging. The median time to neutrophil and platelet engraftment was 21 days for both cohorts and 29 days (in-house) and 33 days (commercial), p = 0.284, respectively.
Conclusion: The in-house BM collection kit offers a real approach to solve the diminished supply of commercial kits. A higher risk of filter clogging was observed compared with commercial kits due to the lack of 850 and 500 μm filters.
Keywords: bone; collection; commercial; in-house; kit; marrow.
© 2023 International Society of Blood Transfusion.
References
REFERENCES
-
- Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant. 2022;57:1217-1239.
-
- EBMT. Transplant activity survey 2022 summary. [cited 2022 Dec 17]. Available from: https://www.ebmt.org/registry/transplant-activity-survey
-
- European Union. Regulation EU 2017/745 on medical devices (medical device regulation, MDR). [cited 2022 Dec 17]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0745
-
- Lanza F, Saccardi R, Seghatchian J. New horizons on stem cell cryopreservation through the artificial eyes of CD34 using modern flow cytometry tools. Transfus Apher Sci. 2020;59:102785.
-
- Thomas ED, Storb R. Technique for human marrow grafting. Blood. 1970;36:507-515.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
